Skip to main content
. 2022 Jul 13;12(3):181–213. doi: 10.3390/jox12030015

Table 4.

Summaries of the disruptive effects of BPA in in vitro studies using human cell lines 1.

Topic Studied Mechanism Concentration Type of Cells Observed Effects References
Ion channels and electrophysiology Nav1.5 channels 1–100 µmol/L HEK-transfected cell line
  • BPA blockage of the channel (Kd = 25.4 ± 1.3 µmol/L);

  • BPA-induced blockage involved the local anesthetic receptor and may have entered the closed-state pore via membrane-located side fenestrations.

[43]
Nav1.5 channels 0.0–100 µmol/L HEK-transfected cell line
  • BPA had a half-maximal inhibitory concentration (IC50) of 55.3 µmol/L and 23.6 µmol/L BPA for fast/peak and late Na+ channel currents

[42]
Nav1.5 channels 1–100 µmol/L hiPSC-CMs
  • BPA significantly inhibited Na+ current channels (IC50 = 56.5 µmol/L)

  • BPA slowed the action potential upstroke (1–100 µmol/L)

  • BPA reduced the action potential amplitude.

[41]
Recombinant human R-type Ca2+ channels 1–100 µmol/L HEK 293 cells
  • BPA included rapid and reversible inhibition of the channels.

  • BPA binding occured with the channel in its resting state, and in the extracellular part not involving intracellular signaling pathways.

[38]
T-type Ca2+ channels 1–100 μmol/L HEK 293 cells
  • BPA appeared to act as a modifier of channel gating and directly plugged the pores of the conductive channel at high concentrations.

[39]
L-type Ca2+ channels Cav1.2 1–100 µmol/L hiPSC-CMs
  • BPA dose-dependently inhibited Ca2+ current channels (IC50 = 6.9 µmol/L).

[41]
Maxi-K channels 100 µmol/L HCASMC
  • BPA increased Maxi-K currents

[35]
Ca2+ handling Ca2+ current channels, Ca2+ transients and contraction 1–100 µmol/L hiPSC-CMs
  • BPA in a dose-dependent manner slowed the Ca2+ transient rise time and decreased the Ca2+ transient amplitude

[41]
Cardiac hypertrophy by disrupting Ca2+ homeostasis 8 ng/mL Human embryonic stem-cell-derived cardiomyocytes
  • BPA induced sex-specific hypertrophic risk in terms of abnormal mitochondrial fission and ATP production by impairing CnAβ-DRP1 signaling

[86]
Vascular endothelium Endothelial dysfunction, inflammation, and angiogenesis 0.1–1 μmol/L HUVECs
  • BPA increased the mRNA expression of the proangiogenic genes and increased NO production

  • BPA increased the expression of phosphorylated eNOS and endothelial tube formation

[88]
Cell division and chromosomal segregation 0.5–10 ng/mL HUVECs
  • BPA at plasma concentrations induced aneugenic effects

[89]
Senescence 10 ng/mL and 1 µg/mL HUVECs
  • BPA impaired transcription and decreased viability in aging vascular EC

[90]
Accelerating atherosclerosis 0.1–10 nmol/L HUVECs
  • BPA appeared to be involved in accelerating atherosclerosis

  • BPA does not altered the HUVEC proliferation or migration

[59]
Pregnancy exposome Epigenetic disruption 35.4–56.1 ng/g Human fetal liver samples
  • Higher levels of BPA with XME genes significantly reduced expression and with increased site-specific methylation at COMT and increased average methylation at SULT2A1 promoters

[91]
0.57 and 0.78 ng/mL Maternal urine samples and Infant cord blood
  • BPA decreased methylation of imprinted and unprinted genes and repetitive element LINE-1

[92]
Pregnancy physiology 1 nmol/L BeWo trophoblast cell line, placental explant cultures, placental perfusions, and skin diffusion models
  • BPA induced cytotoxicity (EC50 = 100–125 µmol/L).

  • BPA significantly increased β-hCG secretion and caspase-3 expression in placental explants.

[95]
0, 0.09, 0.9, and 9.0 μmol/L BeWo trophoblast cell line
  • BPA induced trophoblast cell death under conditions of cellular stress

[96]
1 × 10−15 to 1 × 10−7 mol/L Human trophoblast cells HTR-8/SVneo
  • BPA altered key physiological processes in placenta development

[97]
1 nmol/L Human trophoblast cells HTR-8/SVneo
  • BPA induceed alterations in DNA methylation of stress response and down-regulation of angiogenic growth factors

[98]

1 Legend: BPA—bisphenol A; CnAβ—calcineurin; DRP1—dynamin-related protein 1; HCASMC—human coronary artery smooth muscle cells; HEK—human embryonic kidney; hiPSC-CMs–human-induced pluripotent stem-cell-derived cardiomyocytes; HUVECs—human umbilical vein endothelial cells; IC50—half-maximal inhibitory concentration; LINE-1—long interspersed nuclear element-1 or L1; Maxi-K—large conductance Ca2+/voltage-sensitive K+ channel; XME—xenobiotic-metabolizing enzymes.